BUPRENORPHINE

BUPRENORPHINE was reported 92989 times

BUPRENORPHINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRUG DELIVERY SYSTEM REMOVAL 106 0.8833
1 PLACENTAL HYPERTROPHY 23 0.5750
2 HEPATIC ENZYME 74 0.4966
3 ORAL ADMINISTRATION COMPLICATION 420 0.4516
4 INADEQUATE ANALGESIA 3053 0.3590
5 RHESUS INCOMPATIBILITY 33 0.2727
6 APPLICATION SITE ODOUR 38 0.2621
7 APPLICATION SITE PERSPIRATION 45 0.2601
8 FACET JOINT SYNDROME 733 0.2249
9 APPLICATION SITE RASH 3071 0.2231
10 AMAUROSIS FUGAX 193 0.1792
11 INJECTION SITE EROSION 60 0.1705
12 APPLICATION SITE DISCHARGE 188 0.1629
13 APPLICATION SITE SCAR 200 0.1597
14 APPLICATION SITE VESICLES 1026 0.1580
15 DRUG DETOXIFICATION 137 0.1532
16 PERIPHERAL VENOUS DISEASE 590 0.1443
17 DRUG EFFECT INCREASED 453 0.1432
18 APPLICATION SITE EROSION 184 0.1427
19 APPLICATION SITE BURN 699 0.1418
20 HYPOCHOLESTEROLAEMIA 50 0.1416
21 APPLICATION SITE IRRITATION 1713 0.1375
22 ONYCHOMADESIS 567 0.1350
23 BLEPHAROSPASM 844 0.1339
24 DRUG SCREEN NEGATIVE 235 0.1334
25 APPLICATION SITE REACTION 884 0.1256
26 BREAKTHROUGH PAIN 290 0.1253
27 RHEUMATIC FEVER 552 0.1237
28 DRUG WITHDRAWAL SYNDROME NEONATAL 1790 0.1208
29 BREAST CANCER STAGE III 782 0.1206
30 SWOLLEN JOINT COUNT 27 0.1080
31 DUODENAL ULCER PERFORATION 785 0.1055
32 APPLICATION SITE PRURITUS 2388 0.1051
33 OVERLAP SYNDROME 71 0.1014
34 DRUG LEVEL FLUCTUATING 89 0.1002
35 APPLICATION SITE DISCOLOURATION 402 0.0988
36 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 700 0.0976
37 PRODUCT ADHESION ISSUE 3451 0.0965
38 ONYCHOMYCOSIS 421 0.0959
39 SUBSTANCE USE DISORDER 303 0.0950
40 INJECTION SITE ULCER 89 0.0944
41 APPLICATION SITE URTICARIA 205 0.0912
42 LEARNING DISABILITY 468 0.0878
43 CENTRAL PAIN SYNDROME 22 0.0830
44 DRUG WITHDRAWAL SYNDROME 7064 0.0804
45 APPLICATION SITE PUSTULES 29 0.0795
46 INFUSION SITE REACTION 235 0.0786
47 DRUG DEPENDENCE 12544 0.0779
48 MUSCLE INJURY 646 0.0779
49 PRODUCT SOLUBILITY ABNORMAL 383 0.0758
50 APPLICATION SITE DERMATITIS 70 0.0749
51 FINGER DEFORMITY 360 0.0742
52 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 40 0.0742
53 HELICOBACTER INFECTION 743 0.0722
54 TOOTH EROSION 88 0.0718
55 FOLLICULITIS 748 0.0713
56 CENTRAL SLEEP APNOEA SYNDROME 23 0.0708
57 NAIL DISORDER 610 0.0697
58 LIP DRY 628 0.0691
59 APPLICATION SITE HYPERSENSITIVITY 83 0.0683
60 APPLICATION SITE ERYTHEMA 1777 0.0677
61 LIVE BIRTH 559 0.0668
62 APPLICATION SITE ULCER 47 0.0664
63 PEMPHIGUS 825 0.0659
64 HYPERCHOLESTEROLAEMIA 632 0.0654
65 BURSITIS 788 0.0649
66 TOXICITY TO VARIOUS AGENTS 10813 0.0641
67 C-REACTIVE PROTEIN ABNORMAL 410 0.0639
68 VISCERAL CONGESTION 32 0.0626
69 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 35 0.0624
70 SUBSTANCE ABUSE 502 0.0616
71 ACCIDENTAL POISONING 84 0.0612
72 WOUND INFECTION 665 0.0607
73 C-REACTIVE PROTEIN 56 0.0604
74 LUPUS VULGARIS 76 0.0603
75 HAND DEFORMITY 768 0.0585
76 PRODUCT LABEL CONFUSION 335 0.0574
77 DEEP VEIN THROMBOSIS POSTOPERATIVE 115 0.0574
78 BACK INJURY 618 0.0568
79 DRUG DIVERSION 345 0.0558
80 X-RAY ABNORMAL 99 0.0553
81 APPLICATION SITE INFECTION 28 0.0550
82 GRIP STRENGTH DECREASED 483 0.0548
83 EXPULSION OF MEDICATION 28 0.0529
84 INJECTION SITE INFECTION 168 0.0511
85 OVERDOSE 11012 0.0510
86 INJECTION SITE NECROSIS 103 0.0505
87 DRUG USE DISORDER 422 0.0501
88 APPLICATION SITE BRUISE 48 0.0493
89 DISLOCATION OF VERTEBRA 112 0.0491
90 PLACENTAL DISORDER 46 0.0486
91 INJECTION SITE CELLULITIS 89 0.0478
92 APPLICATION SITE EXFOLIATION 195 0.0473
93 PERICARDITIS 792 0.0471
94 CONGENITAL ANOMALY 364 0.0470
95 MYELOPATHY 88 0.0463
96 DRUG ABUSE 3839 0.0461
97 NEURODEGENERATIVE DISORDER 28 0.0454
98 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 94 0.0453
99 EMOTIONAL DISTRESS 5454 0.0450
100 APPLICATION SITE SCAB 97 0.0449
101 JOINT RANGE OF MOTION DECREASED 602 0.0448
102 SYNOVITIS 792 0.0439
103 VICTIM OF SEXUAL ABUSE 23 0.0437
104 URINARY TRACT DISORDER 195 0.0433
105 APPLICATION SITE PAIN 944 0.0428
106 DEVELOPMENTAL DELAY 386 0.0427
107 COELIAC DISEASE 416 0.0424
108 SWOLLEN JOINT COUNT INCREASED 134 0.0420
109 APPLICATION SITE PAPULES 44 0.0415
110 DRUG TOLERANCE 210 0.0415
111 SUBSTANCE DEPENDENCE 27 0.0401
112 INJECTION SITE ABSCESS 99 0.0397
113 SPINA BIFIDA 82 0.0393
114 APPLICATION SITE INFLAMMATION 54 0.0390
115 OBESITY 612 0.0384
116 DRUG ADMINISTERED AT INAPPROPRIATE SITE 404 0.0383
117 APPLICATION SITE DRYNESS 128 0.0377
118 TASTE DISORDER 755 0.0372
119 MIOSIS 295 0.0367
120 PORPHYRIA ACUTE 52 0.0362
121 NEONATAL RESPIRATORY DISTRESS 34 0.0361
122 EUPHORIC MOOD 361 0.0352
123 GLOSSODYNIA 788 0.0352
124 QUADRIPARESIS 58 0.0349
125 PRODUCT PHYSICAL CONSISTENCY ISSUE 192 0.0347
126 DEFAECATION DISORDER 23 0.0343
127 ALCOHOL ABUSE 91 0.0340
128 BONE EROSION 120 0.0339
129 THERAPEUTIC RESPONSE INCREASED 31 0.0330
130 FIBROMYALGIA 782 0.0321
131 APPLICATION SITE HAEMORRHAGE 87 0.0318
132 DRUG SCREEN POSITIVE 251 0.0317
133 APPLICATION SITE SWELLING 158 0.0317
134 APPLICATION SITE WARMTH 40 0.0313
135 DRUG EFFECT DECREASED 1689 0.0313
136 EPILEPSY 947 0.0309
137 SUBSTANCE USE 48 0.0307
138 IRRITABLE BOWEL SYNDROME 643 0.0300
139 RESPIRATORY DEPRESSION 358 0.0292
140 EXPOSURE VIA BREAST MILK 113 0.0283
141 HAEMORRHAGIC STROKE 221 0.0283
142 WOUND 791 0.0283
143 BRADYPNOEA 76 0.0281
144 LIVER INJURY 690 0.0281
145 RETINITIS 46 0.0266
146 NORMAL NEWBORN 142 0.0261
147 YAWNING 69 0.0258
148 MULTIPLE CONGENITAL ABNORMALITIES 37 0.0257
149 ADVERSE REACTION 339 0.0255
150 ACCIDENTAL OVERDOSE 913 0.0249
151 TYPE 2 DIABETES MELLITUS 819 0.0243
152 POST-TRAUMATIC STRESS DISORDER 163 0.0243
153 SYSTEMIC LUPUS ERYTHEMATOSUS 857 0.0241
154 PRODUCT CONTAMINATION 85 0.0239
155 CONTRAINDICATED PRODUCT ADMINISTERED 717 0.0237
156 SELF ESTEEM DECREASED 57 0.0235
157 APPLICATION SITE DISCOMFORT 42 0.0234
158 WITHDRAWAL SYNDROME 974 0.0232
159 LIVER FUNCTION TEST INCREASED 487 0.0227
160 VICTIM OF CRIME 27 0.0218
161 JAUNDICE NEONATAL 41 0.0216
162 RHEUMATOID FACTOR POSITIVE 123 0.0213
163 C-REACTIVE PROTEIN INCREASED 770 0.0211
164 PSORIATIC ARTHROPATHY 856 0.0211
165 ASPHYXIA 171 0.0209
166 SKIN REACTION 293 0.0208
167 APPLICATION SITE PARAESTHESIA 27 0.0207
168 MATERNAL EXPOSURE DURING PREGNANCY 1846 0.0207
169 COMPARTMENT SYNDROME 54 0.0207
170 BREECH PRESENTATION 26 0.0207
171 IMPAIRED HEALING 671 0.0204
172 DISABILITY 402 0.0203
173 HEPATITIS C 245 0.0203
174 MICROCEPHALY 26 0.0203
175 NIGHT SWEATS 621 0.0193
176 DENTAL CARIES 211 0.0191
177 GAIT INABILITY 637 0.0190
178 HOMICIDE 35 0.0190
179 HYPERAESTHESIA 156 0.0190
180 ALCOHOL INTERACTION 36 0.0185
181 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 311 0.0181
182 IMPRISONMENT 32 0.0181
183 ACCIDENTAL DEATH 33 0.0177
184 GENERALISED OEDEMA 219 0.0177
185 OCULAR DISCOMFORT 198 0.0176
186 AUTOIMMUNE DISORDER 171 0.0175
187 BLISTER 946 0.0168
188 DRUG-INDUCED LIVER INJURY 519 0.0165
189 HEPATITIS 421 0.0164
190 FOETAL EXPOSURE DURING PREGNANCY 1336 0.0164
191 DERMATITIS CONTACT 186 0.0163
192 OSTEOARTHRITIS 689 0.0162
193 LOWER RESPIRATORY TRACT INFECTION 731 0.0161
194 ECHOCARDIOGRAM ABNORMAL 22 0.0157
195 LOGORRHOEA 55 0.0156
196 DEATH 13431 0.0156
197 BLOOD CHOLESTEROL INCREASED 721 0.0155
198 SEDATION 403 0.0154
199 CLUSTER HEADACHE 21 0.0154
200 INFLAMMATION 793 0.0153
201 GUN SHOT WOUND 29 0.0153
202 BREAST CANCER STAGE II 127 0.0152
203 THERAPEUTIC PRODUCT EFFECT DECREASED 682 0.0152
204 LABELLED DRUG-DRUG INTERACTION ISSUE 22 0.0152
205 ARTHROPATHY 845 0.0152
206 PERSECUTORY DELUSION 37 0.0148
207 FOETAL DISTRESS SYNDROME 31 0.0146
208 JUDGEMENT IMPAIRED 21 0.0144
209 ULCER HAEMORRHAGE 97 0.0143
210 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 37 0.0141
211 ALTERED STATE OF CONSCIOUSNESS 301 0.0139
212 EXPOSURE DURING PREGNANCY 858 0.0138
213 THERAPEUTIC RESPONSE DELAYED 38 0.0136
214 PAIN 8340 0.0136
215 INJECTION SITE OEDEMA 23 0.0134
216 LUNG DISORDER 653 0.0133
217 MATERNAL EXPOSURE TIMING UNSPECIFIED 50 0.0133
218 IMPAIRED DRIVING ABILITY 151 0.0133
219 DRUG INTOLERANCE 1273 0.0132
220 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 21 0.0131
221 THERMAL BURN 93 0.0131
222 EXOSTOSIS 119 0.0130
223 PSYCHOMOTOR SKILLS IMPAIRED 34 0.0130
224 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 29 0.0130
225 SKIN IRRITATION 584 0.0127
226 WRONG TECHNIQUE IN DRUG USAGE PROCESS 461 0.0127
227 GENERAL PHYSICAL CONDITION ABNORMAL 86 0.0127
228 INJECTION SITE EXTRAVASATION 156 0.0126
229 MENTAL DISORDER 550 0.0126
230 HEAD DISCOMFORT 223 0.0126
231 BRAIN OEDEMA 159 0.0126
232 WHEEZING 744 0.0125
233 PRODUCT COLOUR ISSUE 64 0.0125
234 STOMATITIS 748 0.0123
235 SMALL FOR DATES BABY 61 0.0123
236 INFUSION RELATED REACTION 810 0.0122
237 HYPOPNOEA 42 0.0121
238 GASTROOESOPHAGEAL REFLUX DISEASE 973 0.0121
239 INTENTIONAL PRODUCT USE ISSUE 1056 0.0120
240 INJURY 842 0.0120
241 EXTRA DOSE ADMINISTERED 483 0.0119
242 EXPOSURE DURING BREAST FEEDING 39 0.0118
243 CLUMSINESS 32 0.0117
244 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 72 0.0116
245 PRODUCT PHYSICAL ISSUE 234 0.0116
246 NECK PAIN 646 0.0115
247 HAEMATEMESIS 291 0.0115
248 DRY MOUTH 927 0.0114
249 CLEFT PALATE 22 0.0114
250 MUSCULOSKELETAL PAIN 595 0.0113
251 PUSTULAR PSORIASIS 39 0.0113
252 INJECTION SITE DISCHARGE 61 0.0113
253 MEDICATION RESIDUE PRESENT 54 0.0113
254 HEPATIC ENZYME INCREASED 759 0.0111
255 PRODUCT PACKAGING DIFFICULT TO OPEN 29 0.0111
256 BEHAVIOUR DISORDER 60 0.0111
257 PHOTOPHOBIA 208 0.0110
258 DRUG TOLERANCE DECREASED 31 0.0110
259 BLOOD PRESSURE DIASTOLIC ABNORMAL 28 0.0110
260 RASH VESICULAR 53 0.0110
261 INTENTIONAL PRODUCT MISUSE 954 0.0109
262 POISONING 136 0.0108
263 SLEEP DISORDER 763 0.0108
264 COMA 510 0.0107
265 TOOTH LOSS 221 0.0106
266 HYPERCAPNIA 32 0.0106
267 ALCOHOL POISONING 28 0.0104
268 FEELING OF BODY TEMPERATURE CHANGE 61 0.0104
269 RED BLOOD CELL SEDIMENTATION RATE INCREASED 115 0.0104
270 TONGUE DISCOMFORT 44 0.0104
271 PRODUCT DISPENSING ISSUE 44 0.0103
272 CONFUSIONAL STATE 1651 0.0102
273 SEDATION COMPLICATION 26 0.0102
274 RESPIRATORY RATE DECREASED 32 0.0102
275 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 66 0.0102
276 PRESCRIBED OVERDOSE 195 0.0101
277 INJECTION SITE INFLAMMATION 50 0.0100
278 DEAFNESS NEUROSENSORY 33 0.0100
279 ENDOCARDITIS 51 0.0099
280 HYPERHIDROSIS 1272 0.0099
281 PRESYNCOPE 239 0.0098
282 GENERAL PHYSICAL HEALTH DETERIORATION 1134 0.0098
283 MIGRAINE 934 0.0098
284 POISONING DELIBERATE 92 0.0097
285 TOOTH INJURY 42 0.0097
286 MOBILITY DECREASED 688 0.0096
287 DERMATITIS ALLERGIC 119 0.0095
288 DIPLOPIA 241 0.0093
289 LUPUS-LIKE SYNDROME 84 0.0093
290 ATTENTION DEFICIT HYPERACTIVITY DISORDER 39 0.0093
291 SWELLING 846 0.0090
292 BRAIN INJURY 90 0.0090
293 LOW BIRTH WEIGHT BABY 71 0.0089
294 SCIATICA 142 0.0089
295 TOOTH FRACTURE 98 0.0089
296 URINARY HESITATION 21 0.0088
297 ROAD TRAFFIC ACCIDENT 365 0.0087
298 DELIRIUM 302 0.0087
299 CARDIO-RESPIRATORY ARREST 362 0.0086
300 WALKING AID USER 57 0.0086
301 SOMNOLENCE 1727 0.0086
302 INJECTION SITE INDURATION 110 0.0085
303 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 601 0.0084
304 ANXIETY DISORDER 28 0.0084
305 INCOHERENT 54 0.0083
306 MENTAL IMPAIRMENT 202 0.0083
307 SEROTONIN SYNDROME 160 0.0083
308 STRESS CARDIOMYOPATHY 48 0.0082
309 ILL-DEFINED DISORDER 501 0.0082
310 SLOW SPEECH 20 0.0082
311 EYE INJURY 25 0.0082
312 ELECTRIC SHOCK SENSATION 23 0.0082
313 PRODUCT SIZE ISSUE 44 0.0082
314 LOWER LIMB FRACTURE 157 0.0082
315 DEPRESSION 1851 0.0081
316 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 149 0.0081
317 FOETAL GROWTH RESTRICTION 49 0.0081
318 QUALITY OF LIFE DECREASED 108 0.0080
319 POTENTIATING DRUG INTERACTION 27 0.0080
320 PARANOIA 138 0.0080
321 SPINAL STENOSIS 33 0.0080
322 ORAL DISCOMFORT 111 0.0080
323 THERAPEUTIC RESPONSE SHORTENED 264 0.0080
324 PREMATURE DELIVERY 126 0.0079
325 DYSPHORIA 40 0.0079
326 RHEUMATOID ARTHRITIS 897 0.0079
327 INJECTION SITE REACTION 543 0.0079
328 NECK INJURY 23 0.0078
329 HYPOAESTHESIA 1160 0.0077
330 INJECTION SITE SCAR 22 0.0077
331 SPINAL FUSION SURGERY 31 0.0076
332 AFFECTIVE DISORDER 60 0.0076
333 SOMNAMBULISM 50 0.0076
334 MONOPLEGIA 33 0.0076
335 COMMUNICATION DISORDER 29 0.0076
336 UNEVALUABLE EVENT 572 0.0076
337 MAJOR DEPRESSION 55 0.0075
338 LOSS OF EMPLOYMENT 22 0.0073
339 CRANIOCEREBRAL INJURY 22 0.0073
340 COMA SCALE ABNORMAL 21 0.0072
341 MEMORY IMPAIRMENT 993 0.0072
342 ASCITES 212 0.0072
343 IMPAIRED WORK ABILITY 154 0.0072
344 RESTLESS LEGS SYNDROME 128 0.0070
345 TREATMENT FAILURE 583 0.0070
346 FEELING DRUNK 52 0.0070
347 HEPATIC FIBROSIS 24 0.0070
348 BRADYKINESIA 41 0.0069
349 INJECTION SITE VESICLES 42 0.0069
350 TACHYPHRENIA 24 0.0069
351 TOXIC ENCEPHALOPATHY 35 0.0069
352 BLINDNESS 281 0.0069
353 HALLUCINATION 519 0.0069
354 IMPAIRED QUALITY OF LIFE 99 0.0069
355 SPONDYLITIS 25 0.0069
356 ASPIRATION 75 0.0068
357 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 487 0.0068
358 TOOTHACHE 123 0.0068
359 EAR PAIN 132 0.0068
360 ALCOHOLISM 29 0.0068
361 DYSARTHRIA 255 0.0068
362 HEPATIC CIRRHOSIS 127 0.0068
363 THERAPEUTIC RESPONSE DECREASED 409 0.0067
364 PARAESTHESIA 1057 0.0067
365 HAEMATURIA 230 0.0067
366 GASTROINTESTINAL DISORDER 601 0.0067
367 TINNITUS 308 0.0067
368 UNRESPONSIVE TO STIMULI 173 0.0067
369 JOINT SWELLING 809 0.0067
370 INTENTIONAL UNDERDOSE 48 0.0066
371 PRODUCT QUALITY ISSUE 890 0.0065
372 MUSCULAR WEAKNESS 742 0.0065
373 AMNESIA 422 0.0065
374 ABDOMINAL PAIN UPPER 1330 0.0065
375 MUSCULOSKELETAL STIFFNESS 564 0.0064
376 DYSPEPSIA 633 0.0064
377 INJECTION SITE HYPERSENSITIVITY 20 0.0064
378 ANXIETY 1788 0.0063
379 TONGUE ULCERATION 21 0.0062
380 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 42 0.0062
381 AGGRESSION 308 0.0061
382 ABDOMINAL DISCOMFORT 1032 0.0061
383 SKIN ABRASION 29 0.0061
384 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 294 0.0061
385 PULMONARY FIBROSIS 117 0.0061
386 PRE-EXISTING CONDITION IMPROVED 38 0.0061
387 DISORIENTATION 241 0.0061
388 MYDRIASIS 78 0.0061
389 TACHYCARDIA 540 0.0061
390 DRUG INTERACTION 964 0.0061
391 MOUTH SWELLING 35 0.0061
392 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1226 0.0060
393 PERSONALITY CHANGE 56 0.0060
394 CONJUNCTIVAL HAEMORRHAGE 23 0.0060
395 RASH 2616 0.0060
396 BIPOLAR DISORDER 65 0.0060
397 PRURITUS GENERALISED 129 0.0060
398 PANIC DISORDER 23 0.0059
399 RESTLESSNESS 215 0.0059
400 BEDRIDDEN 77 0.0059
401 DISCOMFORT 357 0.0058
402 RESPIRATORY ACIDOSIS 23 0.0058
403 PREMATURE BABY 176 0.0058
404 PULMONARY CONGESTION 77 0.0058
405 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 99 0.0058
406 DEPRESSED LEVEL OF CONSCIOUSNESS 230 0.0058
407 NAUSEA 4596 0.0058
408 FOETAL DEATH 30 0.0058
409 INCORRECT PRODUCT ADMINISTRATION DURATION 125 0.0058
410 SUICIDAL BEHAVIOUR 24 0.0058
411 PRESCRIBED UNDERDOSE 115 0.0058
412 PRODUCT FORMULATION ISSUE 38 0.0058
413 RESPIRATORY ARREST 157 0.0057
414 RHABDOMYOLYSIS 236 0.0057
415 PERIPHERAL SWELLING 871 0.0056
416 NEONATAL RESPIRATORY DISTRESS SYNDROME 20 0.0056
417 PNEUMONIA ASPIRATION 141 0.0056
418 PRODUCT ADMINISTRATION ERROR 113 0.0056
419 DIZZINESS 2787 0.0056
420 OVERWEIGHT 30 0.0056
421 COLD SWEAT 98 0.0056
422 SUICIDAL IDEATION 508 0.0055
423 PRODUCT TASTE ABNORMAL 75 0.0055
424 INSOMNIA 1472 0.0055
425 PRODUCT ADMINISTRATION INTERRUPTED 43 0.0055
426 PULMONARY OEDEMA 244 0.0054
427 HOMICIDAL IDEATION 22 0.0054
428 INJECTION SITE IRRITATION 69 0.0054
429 BODY TEMPERATURE DECREASED 53 0.0054
430 BRADYPHRENIA 35 0.0054
431 BONE DENSITY ABNORMAL 20 0.0053
432 AGITATION 392 0.0053
433 URTICARIA 891 0.0053
434 ABDOMINAL DISTENSION 553 0.0053
435 FAECALOMA 29 0.0053
436 VOMITING 2481 0.0053
437 URINARY RETENTION 174 0.0052
438 HEART RATE ABNORMAL 29 0.0052
439 DRUG EFFECT LESS THAN EXPECTED 77 0.0052
440 SOCIAL AVOIDANT BEHAVIOUR 30 0.0052
441 FEELING OF DESPAIR 24 0.0051
442 MUSCLE SPASMS 937 0.0051
443 VENOUS THROMBOSIS 20 0.0051
444 DELUSION 79 0.0051
445 HYPERTONIA 29 0.0051
446 CACHEXIA 26 0.0050
447 PRE-ECLAMPSIA 24 0.0050
448 DISTURBANCE IN ATTENTION 272 0.0050
449 FORMICATION 35 0.0050
450 HALLUCINATIONS, MIXED 21 0.0050
451 LETHARGY 286 0.0050
452 HIP ARTHROPLASTY 76 0.0050
453 MYOCLONUS 59 0.0049
454 PRODUCT PACKAGING ISSUE 47 0.0049
455 DEPENDENCE 271 0.0049
456 MUSCLE RIGIDITY 59 0.0049
457 COGNITIVE DISORDER 230 0.0049
458 SUSPECTED SUICIDE 23 0.0049
459 DRUG INEFFECTIVE 6458 0.0049
460 APNOEA 38 0.0049
461 SUSPECTED OFF LABEL USE 22 0.0049
462 PRODUCT TEMPERATURE EXCURSION ISSUE 25 0.0049
463 PRODUCT PRESCRIBING ISSUE 106 0.0049
464 GASTROINTESTINAL MOTILITY DISORDER 26 0.0049
465 DRUG EFFECT DELAYED 22 0.0048
466 SUICIDE ATTEMPT 294 0.0048
467 BLOOD PRESSURE SYSTOLIC DECREASED 22 0.0048
468 HYPERTENSION 1022 0.0048
469 ABNORMAL BEHAVIOUR 189 0.0048
470 RESPIRATORY DISORDER 142 0.0047
471 PRODUCT PRESCRIBING ERROR 113 0.0047
472 TORSADE DE POINTES 37 0.0047
473 SCREAMING 30 0.0047
474 HALLUCINATION, VISUAL 98 0.0046
475 BRUXISM 25 0.0046
476 SPINAL OPERATION 57 0.0046
477 TOOTH DISORDER 102 0.0046
478 ABNORMAL LOSS OF WEIGHT 31 0.0045
479 JOINT STIFFNESS 118 0.0045
480 HYPERVENTILATION 26 0.0045
481 PSYCHOTIC DISORDER 132 0.0045
482 CONSTIPATION 973 0.0045
483 ALOPECIA 876 0.0045
484 HYPERTHERMIA 34 0.0044
485 SCHIZOPHRENIA 54 0.0044
486 FEELING ABNORMAL 1049 0.0044
487 OEDEMA 237 0.0044
488 FEELING JITTERY 83 0.0044
489 ACCIDENT 52 0.0044
490 JOINT DISLOCATION 46 0.0043
491 SLEEP APNOEA SYNDROME 83 0.0043
492 MYOSITIS 39 0.0043
493 HALLUCINATION, AUDITORY 69 0.0043
494 NERVE INJURY 48 0.0043
495 THINKING ABNORMAL 80 0.0043
496 NASOPHARYNGITIS 786 0.0043
497 SKIN NECROSIS 22 0.0042
498 ANGER 143 0.0042
499 CARDIOMEGALY 52 0.0042
500 PRODUCT USE ISSUE 785 0.0042
501 MATERNAL DRUGS AFFECTING FOETUS 32 0.0042
502 SYNCOPE 410 0.0041
503 DECREASED INTEREST 24 0.0041
504 OEDEMA PERIPHERAL 496 0.0041
505 BLOOD PRESSURE DIASTOLIC DECREASED 30 0.0041
506 DEVICE LEAKAGE 176 0.0041
507 HYPERSOMNIA 116 0.0040
508 CONDITION AGGRAVATED 1230 0.0040
509 EYE PAIN 228 0.0040
510 ASTHENIA 1519 0.0040
511 CHILLS 469 0.0040
512 APATHY 58 0.0040
513 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35 0.0040
514 FALL 1304 0.0039
515 PRODUCT SUBSTITUTION ISSUE 225 0.0039
516 INTERVERTEBRAL DISC DEGENERATION 36 0.0039
517 CYANOSIS 61 0.0039
518 RESPIRATORY DISTRESS 107 0.0039
519 HYPOTHERMIA 39 0.0038
520 HEADACHE 2414 0.0038
521 FAECES SOFT 28 0.0038
522 WEIGHT INCREASED 862 0.0038
523 SEXUAL DYSFUNCTION 45 0.0038
524 RASH GENERALISED 99 0.0038
525 CARDIAC DISORDER 356 0.0038
526 BLOOD TESTOSTERONE DECREASED 26 0.0038
527 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 685 0.0038
528 SPINAL OSTEOARTHRITIS 33 0.0038
529 SPINAL PAIN 44 0.0038
530 LOSS OF CONSCIOUSNESS 481 0.0038
531 PANIC REACTION 27 0.0037
532 GENERAL SYMPTOM 28 0.0037
533 DECREASED APPETITE 865 0.0037
534 PRODUCT ODOUR ABNORMAL 39 0.0037
535 PRODUCT USE IN UNAPPROVED INDICATION 921 0.0037
536 NEUROLEPTIC MALIGNANT SYNDROME 44 0.0037
537 GINGIVITIS 20 0.0037
538 HYPERSENSITIVITY 684 0.0037
539 DRUG LEVEL INCREASED 60 0.0036
540 SUDDEN DEATH 38 0.0036
541 SPUTUM DISCOLOURED 34 0.0036
542 ENERGY INCREASED 21 0.0036
543 LIVER DISORDER 157 0.0035
544 DRUG LEVEL DECREASED 36 0.0035
545 IMPAIRED GASTRIC EMPTYING 48 0.0035
546 ARTHRALGIA 1459 0.0035
547 MALAISE 1536 0.0035
548 NEURALGIA 85 0.0035
549 SENSORY DISTURBANCE 56 0.0035
550 ARTERIOSCLEROSIS CORONARY ARTERY 23 0.0035
551 DEMENTIA 97 0.0035
552 UROSEPSIS 32 0.0035
553 LOSS OF LIBIDO 31 0.0034
554 SCAR 59 0.0034
555 BACK DISORDER 56 0.0034
556 PANIC ATTACK 125 0.0034
557 PRODUCT USE COMPLAINT 54 0.0034
558 PHARYNGITIS STREPTOCOCCAL 37 0.0034
559 DRUG ABUSER 21 0.0034
560 UNDERDOSE 248 0.0034
561 MALNUTRITION 38 0.0034
562 NIGHTMARE 117 0.0034
563 CONTUSION 324 0.0034
564 FACIAL PAIN 30 0.0034
565 INJECTION SITE WARMTH 69 0.0034
566 ENCEPHALOPATHY 82 0.0033
567 INJECTION SITE PAIN 1024 0.0033
568 MOOD SWINGS 106 0.0033
569 ERECTILE DYSFUNCTION 85 0.0033
570 SEPSIS 368 0.0033
571 PRODUCT COMMUNICATION ISSUE 29 0.0033
572 KNEE ARTHROPLASTY 69 0.0033
573 IRRITABILITY 197 0.0033
574 INTENTIONAL SELF-INJURY 66 0.0033
575 GINGIVAL PAIN 26 0.0033
576 SEIZURE 377 0.0033
577 MUSCLE TWITCHING 75 0.0033
578 SOPOR 43 0.0032
579 DYSURIA 119 0.0032
580 ABDOMINAL PAIN 748 0.0032
581 PRODUCT DISPENSING ERROR 70 0.0032
582 DYSPNOEA 1808 0.0032
583 LIP SWELLING 106 0.0032
584 ADVERSE DRUG REACTION 285 0.0032
585 NO ADVERSE EVENT 573 0.0032
586 PRURITUS 1213 0.0032
587 COORDINATION ABNORMAL 44 0.0032
588 LOCAL SWELLING 55 0.0031
589 UPPER GASTROINTESTINAL HAEMORRHAGE 53 0.0031
590 PREGNANCY 63 0.0031
591 COMPLETED SUICIDE 262 0.0031
592 SENSITIVE SKIN 23 0.0031
593 CEREBRAL DISORDER 23 0.0031
594 ORTHOSTATIC HYPOTENSION 54 0.0031
595 PNEUMONIA 1002 0.0031
596 DIZZINESS POSTURAL 30 0.0031
597 ADVERSE EVENT 284 0.0031
598 INJECTION SITE ERYTHEMA 382 0.0031
599 DROOLING 21 0.0030
600 PAIN IN EXTREMITY 886 0.0030
601 MEDICATION ERROR 167 0.0030
602 FEELING HOT 184 0.0030
603 BRAIN FOG 47 0.0030
604 ILLNESS 307 0.0030
605 TREMOR 494 0.0030
606 ELECTROCARDIOGRAM QT PROLONGED 107 0.0030
607 URINARY INCONTINENCE 88 0.0030
608 THERAPY NON-RESPONDER 133 0.0030
609 OSTEOPOROSIS 121 0.0029
610 PALPITATIONS 344 0.0029
611 INTENTIONAL OVERDOSE 188 0.0029
612 MUSCLE SPASTICITY 36 0.0029
613 CAESAREAN SECTION 34 0.0029
614 INJECTION SITE NODULE 32 0.0029
615 RESPIRATION ABNORMAL 20 0.0029
616 FOOT DEFORMITY 32 0.0029
617 POOR QUALITY SLEEP 62 0.0029
618 GASTRIC ULCER 54 0.0028
619 INJECTION SITE MASS 105 0.0028
620 BLOOD PRESSURE INCREASED 430 0.0028
621 HYPOXIA 99 0.0028
622 IMMUNE SYSTEM DISORDER 37 0.0028
623 HYDRONEPHROSIS 21 0.0028
624 HYPOTONIA 28 0.0028
625 SALIVARY HYPERSECRETION 28 0.0028
626 RIB FRACTURE 57 0.0028
627 INJECTION SITE DISCOMFORT 29 0.0028
628 TOOTH ABSCESS 28 0.0027
629 TOOTH EXTRACTION 34 0.0027
630 FREQUENT BOWEL MOVEMENTS 73 0.0027
631 SWOLLEN TONGUE 84 0.0027
632 TENDERNESS 28 0.0027
633 MUSCLE ATROPHY 34 0.0027
634 INTENTIONAL DRUG MISUSE 56 0.0027
635 CHEST PAIN 495 0.0027
636 ACUTE RESPIRATORY DISTRESS SYNDROME 47 0.0027
637 BURNING SENSATION 186 0.0026
638 BLOOD ALBUMIN DECREASED 21 0.0026
639 HOSPITALISATION 406 0.0026
640 INJECTION SITE DISCOLOURATION 33 0.0026
641 FATIGUE 2054 0.0026
642 FOOT FRACTURE 50 0.0026
643 MENTAL STATUS CHANGES 73 0.0026
644 FEELING COLD 73 0.0026
645 MYALGIA 444 0.0026
646 OFF LABEL USE 2273 0.0026
647 POLYNEUROPATHY 31 0.0026
648 CRYING 94 0.0026
649 WEIGHT FLUCTUATION 27 0.0026
650 OXYGEN SATURATION DECREASED 145 0.0026
651 CARDIAC ARREST 213 0.0026
652 DEPRESSED MOOD 135 0.0026
653 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 133 0.0025
654 SCAB 29 0.0025
655 DEVICE ADHESION ISSUE 39 0.0025
656 GENERALISED TONIC-CLONIC SEIZURE 42 0.0025
657 CHROMATURIA 57 0.0025
658 INJECTION SITE PRURITUS 168 0.0025
659 TACHYPNOEA 34 0.0025
660 CARPAL TUNNEL SYNDROME 35 0.0025
661 BLOOD DISORDER 20 0.0025
662 AFFECT LABILITY 24 0.0025
663 MOOD ALTERED 68 0.0025
664 DIARRHOEA 1605 0.0025
665 HYPOKINESIA 36 0.0025
666 VISION BLURRED 340 0.0025
667 ASTHMA 279 0.0025
668 SINUS TACHYCARDIA 35 0.0025
669 SCRATCH 26 0.0025
670 ARTERIOSCLEROSIS 23 0.0024
671 MANIA 40 0.0024
672 ANKYLOSING SPONDYLITIS 32 0.0024
673 NERVOUSNESS 126 0.0024
674 PSYCHOMOTOR HYPERACTIVITY 40 0.0024
675 EAR INFECTION 64 0.0024
676 DRUG PRESCRIBING ERROR 46 0.0024
677 ATRIAL SEPTAL DEFECT 20 0.0024
678 IMMUNOSUPPRESSION 21 0.0024
679 INJECTION SITE SWELLING 182 0.0024
680 POOR QUALITY PRODUCT ADMINISTERED 25 0.0024
681 DRUG EFFECT INCOMPLETE 86 0.0024
682 ATAXIA 28 0.0024
683 LACRIMATION INCREASED 71 0.0023
684 VERTIGO 143 0.0023
685 HEART RATE IRREGULAR 53 0.0023
686 BALANCE DISORDER 202 0.0023
687 HOT FLUSH 176 0.0023
688 HYPOAESTHESIA ORAL 35 0.0023
689 SKIN INFECTION 26 0.0023
690 SKIN LACERATION 25 0.0023
691 DYSSTASIA 67 0.0023
692 BLOOD PRESSURE FLUCTUATION 55 0.0023
693 TRANSFUSION 24 0.0023
694 NERVOUS SYSTEM DISORDER 71 0.0023
695 EMOTIONAL DISORDER 69 0.0022
696 TEMPERATURE INTOLERANCE 23 0.0022
697 ABORTION SPONTANEOUS 89 0.0022
698 GAIT DISTURBANCE 425 0.0022
699 BACK PAIN 511 0.0022
700 ACUTE KIDNEY INJURY 335 0.0022
701 MICTURITION URGENCY 25 0.0022
702 BLOOD CREATINE PHOSPHOKINASE INCREASED 63 0.0022
703 SURGERY 128 0.0022
704 INFECTION 316 0.0022
705 FULL BLOOD COUNT ABNORMAL 23 0.0022
706 CIRCULATORY COLLAPSE 37 0.0022
707 HYPOKALAEMIA 100 0.0022
708 CELLULITIS 109 0.0022
709 SWELLING FACE 140 0.0021
710 NEPHROPATHY 20 0.0021
711 DYSKINESIA 87 0.0021
712 LIMB INJURY 58 0.0021
713 HEAD INJURY 67 0.0021
714 HYPOTENSION 424 0.0021
715 ECONOMIC PROBLEM 32 0.0021
716 OSTEOPENIA 32 0.0021
717 PRODUCT AVAILABILITY ISSUE 48 0.0021
718 JOINT INJURY 45 0.0021
719 OSTEOMYELITIS 38 0.0021
720 SNEEZING 47 0.0021
721 BRADYCARDIA 111 0.0021
722 HYPOGLYCAEMIA 101 0.0021
723 FEAR 56 0.0021
724 SKIN LESION 57 0.0021
725 WEIGHT DECREASED 577 0.0021
726 METABOLIC ACIDOSIS 66 0.0021
727 DYSTONIA 40 0.0021
728 GOUT 37 0.0021
729 ADRENAL INSUFFICIENCY 25 0.0021
730 INTERVERTEBRAL DISC PROTRUSION 45 0.0021
731 INITIAL INSOMNIA 21 0.0020
732 SPINAL FRACTURE 41 0.0020
733 INFLUENZA LIKE ILLNESS 168 0.0020
734 MOUTH ULCERATION 43 0.0020
735 PERIPHERAL COLDNESS 28 0.0020
736 HEART RATE INCREASED 202 0.0020
737 DYSPHAGIA 193 0.0020
738 CARDIOMYOPATHY 30 0.0020
739 TREATMENT NONCOMPLIANCE 111 0.0020
740 INJECTION SITE RASH 62 0.0020
741 PARAESTHESIA ORAL 29 0.0020
742 WRIST FRACTURE 24 0.0020
743 SINUS CONGESTION 27 0.0020
744 FEEDING DISORDER 40 0.0020
745 SLUGGISHNESS 20 0.0020
746 RESPIRATORY TRACT INFECTION 51 0.0020
747 DECREASED ACTIVITY 21 0.0019
748 LOCALISED INFECTION 47 0.0019
749 ANKLE FRACTURE 30 0.0019
750 RECTAL HAEMORRHAGE 83 0.0019
751 MOVEMENT DISORDER 62 0.0019
752 STAPHYLOCOCCAL INFECTION 63 0.0019
753 MULTIPLE ORGAN DYSFUNCTION SYNDROME 54 0.0019
754 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0019
755 PYREXIA 653 0.0019
756 PARALYSIS 27 0.0019
757 EATING DISORDER 40 0.0019
758 EYE HAEMORRHAGE 25 0.0019
759 PELVIC PAIN 34 0.0019
760 ACUTE RESPIRATORY FAILURE 36 0.0019
761 HYPONATRAEMIA 105 0.0019
762 INTENTIONAL DOSE OMISSION 53 0.0019
763 LIVER FUNCTION TEST ABNORMAL 54 0.0019
764 APHASIA 56 0.0019
765 ABNORMAL DREAMS 51 0.0018
766 UPPER RESPIRATORY TRACT INFECTION 85 0.0018
767 METASTASES TO BONE 30 0.0018
768 RHINORRHOEA 118 0.0018
769 SINUSITIS 187 0.0018
770 PHARYNGEAL OEDEMA 28 0.0018
771 METASTASES TO LUNG 21 0.0018
772 ABSCESS 29 0.0018
773 ELECTROLYTE IMBALANCE 21 0.0018
774 ARTHRITIS 142 0.0018
775 PALLOR 49 0.0018
776 SKIN DISORDER 60 0.0018
777 NEUROPATHY PERIPHERAL 171 0.0018
778 HYPOCALCAEMIA 34 0.0018
779 ARRHYTHMIA 85 0.0018
780 HUNGER 25 0.0018
781 SKIN ULCER 46 0.0018
782 WHITE BLOOD CELL COUNT INCREASED 68 0.0018
783 TOOTH INFECTION 23 0.0017
784 INJECTION SITE BRUISING 139 0.0017
785 THROAT TIGHTNESS 47 0.0017
786 PROCEDURAL PAIN 48 0.0017
787 HEPATIC CYTOLYSIS 22 0.0017
788 PANCREATITIS 91 0.0017
789 ACTIVITIES OF DAILY LIVING IMPAIRED 34 0.0017
790 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 94 0.0017
791 INTESTINAL OBSTRUCTION 64 0.0017
792 THERAPEUTIC RESPONSE UNEXPECTED 76 0.0017
793 CHOKING 33 0.0017
794 RETCHING 36 0.0017
795 KIDNEY INFECTION 33 0.0017
796 HEART RATE DECREASED 59 0.0017
797 IMMUNODEFICIENCY 25 0.0017
798 ORAL CANDIDIASIS 22 0.0017
799 ULCER 26 0.0016
800 FLUID RETENTION 83 0.0016
801 HYPOTHYROIDISM 52 0.0016
802 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
803 CHEST DISCOMFORT 166 0.0016
804 EXTRAPYRAMIDAL DISORDER 40 0.0016
805 ACUTE HEPATIC FAILURE 22 0.0016
806 RASH PRURITIC 87 0.0016
807 LABORATORY TEST ABNORMAL 47 0.0016
808 LIMB DISCOMFORT 49 0.0016
809 PNEUMOTHORAX 25 0.0016
810 DERMATITIS 33 0.0016
811 BODY TEMPERATURE INCREASED 32 0.0016
812 SPEECH DISORDER 82 0.0016
813 RESPIRATORY FAILURE 114 0.0016
814 POLLAKIURIA 65 0.0016
815 NEUROTOXICITY 27 0.0015
816 BONE PAIN 89 0.0015
817 ORAL PAIN 34 0.0015
818 INSURANCE ISSUE 23 0.0015
819 COUGH 421 0.0015
820 SKIN BURNING SENSATION 106 0.0015
821 FAECES DISCOLOURED 32 0.0015
822 ERYTHEMA 302 0.0015
823 VISUAL IMPAIRMENT 182 0.0015
824 MELAENA 32 0.0015
825 DYSPHONIA 85 0.0015
826 LEUKOCYTOSIS 26 0.0014
827 ANGINA PECTORIS 41 0.0014
828 URINARY TRACT INFECTION 244 0.0014
829 LEUKOPENIA 71 0.0014
830 PRODUCT DOSE OMISSION IN ERROR 40 0.0014
831 THERAPY CESSATION 72 0.0014
832 PNEUMONITIS 38 0.0014
833 MUSCULOSKELETAL DISCOMFORT 24 0.0014
834 CARDIOGENIC SHOCK 20 0.0014
835 RENAL IMPAIRMENT 117 0.0014
836 HAEMORRHOIDS 27 0.0014
837 FRACTURE 26 0.0014
838 BRONCHITIS 101 0.0014
839 DEHYDRATION 182 0.0014
840 APHONIA 19 0.0014
841 MUSCLE TIGHTNESS 22 0.0014
842 SEPTIC SHOCK 59 0.0014
843 ISCHAEMIC STROKE 24 0.0013
844 HYPOPHAGIA 34 0.0013
845 CARDIAC FAILURE 106 0.0013
846 RENAL DISORDER 61 0.0013
847 NEPHROLITHIASIS 60 0.0013
848 CHRONIC KIDNEY DISEASE 99 0.0013
849 PRODUCT COMPLAINT 33 0.0013
850 ANHEDONIA 34 0.0013
851 HEPATIC FAILURE 39 0.0013
852 BLOOD POTASSIUM INCREASED 21 0.0013
853 MUSCULOSKELETAL CHEST PAIN 20 0.0013
854 BLOOD PRESSURE DECREASED 85 0.0013
855 MULTIPLE FRACTURES 21 0.0013
856 JAUNDICE 34 0.0013
857 ATRIAL FIBRILLATION 123 0.0013
858 SINUS DISORDER 25 0.0013
859 TRANSAMINASES INCREASED 28 0.0013
860 INCREASED APPETITE 24 0.0013
861 PULMONARY EMBOLISM 119 0.0013
862 OROPHARYNGEAL PAIN 115 0.0012
863 DYSGEUSIA 91 0.0012
864 VENTRICULAR TACHYCARDIA 20 0.0012
865 PHOTOSENSITIVITY REACTION 20 0.0012
866 DRUG ADMINISTRATION ERROR 37 0.0012
867 COAGULOPATHY 20 0.0012
868 PULMONARY HYPERTENSION 25 0.0012
869 HAEMATOMA 31 0.0012
870 ACUTE MYOCARDIAL INFARCTION 35 0.0012
871 COLITIS ULCERATIVE 53 0.0012
872 HIP FRACTURE 38 0.0012
873 GASTRITIS 31 0.0012
874 GALLBLADDER DISORDER 21 0.0012
875 PAIN IN JAW 33 0.0012
876 FEMUR FRACTURE 36 0.0012
877 DRY EYE 58 0.0012
878 CHOLELITHIASIS 38 0.0012
879 RENAL FAILURE 153 0.0012
880 END STAGE RENAL DISEASE 21 0.0012
881 PAIN OF SKIN 31 0.0012
882 CHOLESTASIS 22 0.0011
883 INJECTION SITE URTICARIA 28 0.0011
884 TARDIVE DYSKINESIA 32 0.0011
885 RASH ERYTHEMATOUS 54 0.0011
886 DEEP VEIN THROMBOSIS 73 0.0011
887 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
888 PRODUCT PREPARATION ERROR 23 0.0011
889 HYPERKALAEMIA 39 0.0011
890 UPPER LIMB FRACTURE 22 0.0011
891 HEPATIC FUNCTION ABNORMAL 41 0.0011
892 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24 0.0011
893 GASTRIC DISORDER 37 0.0011
894 OCULAR HYPERAEMIA 51 0.0011
895 CARDIAC FAILURE CONGESTIVE 86 0.0011
896 RENAL FAILURE ACUTE 45 0.0011
897 INTERNATIONAL NORMALISED RATIO INCREASED 30 0.0011
898 MUSCULOSKELETAL DISORDER 20 0.0010
899 ANAPHYLACTIC REACTION 58 0.0010
900 SKIN DISCOLOURATION 48 0.0010
901 CEREBRAL HAEMORRHAGE 37 0.0010
902 GASTROINTESTINAL HAEMORRHAGE 85 0.0010
903 CONVULSION 58 0.0010
904 AGEUSIA 25 0.0010
905 PRODUCT DOSE OMISSION ISSUE 294 0.0010
906 INFLUENZA 110 0.0010
907 PLEURAL EFFUSION 60 0.0010
908 DYSPNOEA EXERTIONAL 37 0.0010
909 DIVERTICULITIS 27 0.0010
910 ANAEMIA 185 0.0010
911 ANAPHYLACTIC SHOCK 25 0.0010
912 HAEMATOCHEZIA 53 0.0010
913 CEREBROVASCULAR ACCIDENT 162 0.0010
914 BLOOD PRESSURE ABNORMAL 19 0.0010
915 INCORRECT ROUTE OF DRUG ADMINISTRATION 34 0.0010
916 ANGIOEDEMA 42 0.0009
917 TRANSIENT ISCHAEMIC ATTACK 32 0.0009
918 FUNGAL INFECTION 31 0.0009
919 INCORRECT DRUG ADMINISTRATION DURATION 26 0.0009
920 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 43 0.0009
921 PSORIASIS 120 0.0009
922 RASH MACULAR 32 0.0009
923 EYE SWELLING 34 0.0009
924 EPISTAXIS 68 0.0009
925 HYPERGLYCAEMIA 33 0.0009
926 FLUSHING 92 0.0009
927 FLATULENCE 50 0.0009
928 SKIN EXFOLIATION 74 0.0009
929 INCORRECT DOSE ADMINISTERED 197 0.0009
930 THROMBOCYTOPENIA 96 0.0009
931 CYSTITIS 27 0.0008
932 PRODUCT DOSE OMISSION 55 0.0008
933 NASAL CONGESTION 49 0.0008
934 MYOCARDIAL INFARCTION 145 0.0008
935 ACCIDENTAL EXPOSURE TO PRODUCT 85 0.0008
936 HAEMOPTYSIS 23 0.0008
937 NEEDLE ISSUE 24 0.0008
938 NEOPLASM MALIGNANT 55 0.0008
939 PANCYTOPENIA 46 0.0008
940 ECZEMA 43 0.0008
941 THROMBOSIS 66 0.0008
942 PRODUCTIVE COUGH 39 0.0008
943 ABASIA 20 0.0008
944 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
945 COLITIS 30 0.0008
946 RENAL INJURY 23 0.0008
947 LYMPHADENOPATHY 27 0.0008
948 OSTEONECROSIS 25 0.0008
949 THERAPY INTERRUPTED 54 0.0008
950 MULTIPLE SCLEROSIS 36 0.0008
951 ABDOMINAL PAIN LOWER 19 0.0008
952 BLOOD CREATININE INCREASED 47 0.0007
953 INJECTION SITE HAEMORRHAGE 57 0.0007
954 DEVICE MALFUNCTION 50 0.0007
955 PRODUCT STORAGE ERROR 61 0.0007
956 CORONARY ARTERY DISEASE 21 0.0007
957 EXPIRED PRODUCT ADMINISTERED 23 0.0007
958 THROAT IRRITATION 31 0.0007
959 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 20 0.0007
960 DIABETES MELLITUS 52 0.0007
961 HAEMORRHAGE 70 0.0007
962 EYE DISORDER 22 0.0007
963 COVID-19 117 0.0007
964 BLOOD POTASSIUM DECREASED 20 0.0007
965 NEOPLASM PROGRESSION 23 0.0007
966 VIRAL INFECTION 22 0.0007
967 ALANINE AMINOTRANSFERASE INCREASED 40 0.0007
968 HYPOACUSIS 28 0.0006
969 HERPES ZOSTER 37 0.0006
970 EYE PRURITUS 21 0.0006
971 MALIGNANT NEOPLASM PROGRESSION 63 0.0006
972 VAGINAL HAEMORRHAGE 26 0.0006
973 HAEMOGLOBIN DECREASED 59 0.0006
974 NEUTROPENIA 78 0.0006
975 CATARACT 34 0.0006
976 NEUTROPHIL COUNT DECREASED 22 0.0005
977 PLASMA CELL MYELOMA 20 0.0005
978 MULTIPLE SCLEROSIS RELAPSE 34 0.0005
979 DRY SKIN 64 0.0005
980 BLOOD GLUCOSE DECREASED 23 0.0005
981 DISEASE PROGRESSION 54 0.0005
982 FEBRILE NEUTROPENIA 28 0.0004
983 DISEASE RECURRENCE 20 0.0004
984 DEVICE ISSUE 36 0.0004
985 ACNE 30 0.0004
986 PLATELET COUNT DECREASED 41 0.0004
987 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
988 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
989 BLOOD GLUCOSE INCREASED 57 0.0003
990 DRUG DOSE OMISSION 41 0.0002